{SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Eli Lilly, L, Lipids in Cell Signaling, Phospholipase Inhibitors, Phospholipid Metabolism, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Cell Biology, Cell Signaling and Neuroscience, Eli Lilly, L, Lipids in Cell Signaling, Phospholipase Inhibitors, Phospholipid Metabolism
相关文献及参考
Schevitz, R.W., et al., Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Nat. Struct. Biol. 2 , 458-465, (1995) 摘要
Fleisch, J.H, et al., Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor. J. Pharmacol. Exp. Ther. 278 , 252-257, (1996)
Bidgood, M.J., et al., Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes. J. Immunol. 165 , 2790-2797, (2000) 摘要